
    
      In this 3-treatment, 3-period, 6-sequence crossover study, each subject will receive all 3
      products in randomized order, 1 product at a time, with a washout period of 24 hours between
      treatment periods. Following instillation of study medication, subjects will complete a
      3-minute discomfort profile.
    
  